Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSI) Interest Expenses (2022 - 2025)

TriSalus Life Sciences (TLSI) has 3 years of Interest Expenses data on record, last reported at $1.5 million in Q4 2025.

  • For Q4 2025, Interest Expenses rose 35.96% year-over-year to $1.5 million; the TTM value through Dec 2025 reached $5.5 million, up 79.42%, while the annual FY2025 figure was $5.5 million, 79.42% up from the prior year.
  • Interest Expenses reached $1.5 million in Q4 2025 per TLSI's latest filing, down from $1.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.5 million in Q3 2025 and bottomed at $3000.0 in Q4 2023.
  • Average Interest Expenses over 3 years is $720833.3, with a median of $972500.0 recorded in 2024.
  • Peak YoY movement for Interest Expenses: crashed 40.0% in 2024, then surged 40200.0% in 2025.
  • A 3-year view of Interest Expenses shows it stood at $3000.0 in 2023, then soared by 35500.0% to $1.1 million in 2024, then skyrocketed by 35.96% to $1.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $1.5 million in Q4 2025, $1.5 million in Q3 2025, and $1.4 million in Q2 2025.